HomeCompaniesProfile

Macromoltek

Computational antibody design 


Company Size

11 - 50 employees

Year Founded

2010


About Macromoltek

Macromoltek: Revolutionizing antibody design.

Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Founders & Key People

Monica Berrondo

Monica Berrondo

Founder/CEO, Macromoltek

Susana Kaufmann

Susana Kaufmann

Co-founder of Macromoltek

Share This Profile

More Companies

Actiondesk

Access all your live data in one place

voize

App for healthcare workers to fill out forms using speech

Rev Genomics

Rev is a biotechnology company creating better plants.

Millibatt, Inc.

Nuvola is transforming battery manufacturing, making EV batteries…

Kraftful

Copilot for product teams

Quilt Data

Quilt manages data like code so that companies can experiment faster

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.